IPMCL-28b

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameIPMCL-28b
Drug Alias NameIPMCL-28b
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsBacterial DNA gyraseTopoisomerase IV
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang UniversityLanzhou UniversityJinan University +[5] 
China Registration ClassN/A

Develop Information

Active CompaniesColumbia UniversityLanzhou UniversityNanjing University Of Chinese Medicine +[5] 
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A